Biotech IPOs: Who Needs Them?

Initial public offerings from biotech companies have slowed to a crawl. That isn’t as big a problem for biotech stocks as one might expect.

from WSJ.com: Markets http://ift.tt/2qvE85I
via https://ifttt.com/ IFTTT